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Resistance to respiratory disease in cattle requires host defense mechanisms that protect against pathogens which
have evolved sophisticated strategies to evade them, including an altered function of pulmonary macrophages (MΦs)
or the induction of inflammatory responses that cause lung injury and sepsis. The aim of this study was to clarify the
mechanisms responsible for vascular changes occurring in the lungs of calves infected with bovine viral diarrhea virus
(BVDV) and challenged later with bovine herpesvirus type 1 (BHV-1), evaluating the role of MΦs in the development of
pathological lesions in this organ. For this purpose, pulmonary lesions were compared between co-infected calves and
healthy animals inoculated only with BHV-1 through immunohistochemical (MAC387, TNFα, IL-1α, iNOS, COX-2 and
Factor-VIII) and ultrastructural studies. Both groups of calves presented important vascular alterations produced by
fibrin microthrombi and platelet aggregations within the blood vessels. These findings were earlier and more severe in
the co-infected group, indicating that the concomitance of BVDV and BHV-1 in the lungs disrupts the pulmonary
homeostasis by facilitating the establishment of an inflammatory and procoagulant environment modulated by
inflammatory mediators released by pulmonary MΦs. In this regard, the co-infected calves, in spite of presenting a
greater number of IMΦs than single-infected group, show a significant decrease in iNOS expression coinciding with the
presence of more coagulation lesions. Moreover, animals pre-inoculated with BVDV displayed an alteration in the
response of pro-inflammatory cytokines (TNFα and IL-1), which play a key role in activating the immune response, as
well as in the local cell-mediated response.Introduction
The bovine respiratory disease complex (BRDC) is an im-
portant problem for the cattle industry, often resulting in se-
vere economic losses [1,2]. This fatal bovine respiratory
infection is a multi-factorial disease associated with a pri-
mary viral infection followed by a secondary bacterial infec-
tion. It is frequently characterized by concurrent infections
of several pathogens. The etiologic agents related to feedlot
pneumonias include bovine viral diarrhea virus 1 and 2
(BVDV-1 and BVDV-2), bovine herpesvirus type 1 (BHV-1),
bovine parainfluenza-3 virus, bovine respiratory syncytial
virus, bovine adenovirus, bovine coronavirus, Mannheimia
haemolytica, Pasteurella multocida, Histophilus somni and* Correspondence: jcgomez@uco.es
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reproduction in any medium, provided the orMycoplasma spp. [3-6]. Resistance to respiratory disease in
cattle requires host defense mechanisms that protect against
viral and bacterial pathogens that have also evolved sophisti-
cated strategies to evade the host immune responses, includ-
ing among others an altered pulmonary macrophages
(MΦs) function or the induction of profound inflammatory
responses that cause lung injury and sepsis [6].
The inflammatory process is a protective mechanism
that occurs in response to trauma, infection or tissue injury
[7,8]. Increased blood supply, enhanced vascular perme-
ability and migration of immune cells occur at damaged
sites. In this process, MΦs play a central role in managing
different immunopathological phenomena through the
secretion of inflammatory mediators such as nitric
oxide (NO), prostaglandins, and the pro-inflammatory
cytokines tumor necrosis factor-α (TNFα) and inter-
leukin (IL)-1 [9-11].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tone and function within the vessel wall, generated from
L-arginine by nitric oxide synthase (NOS) enzymes. There
are three main isoforms of NOS with distinct functions
and patterns of expression: endothelial NOS, neuronal
NOS and inducible NOS (iNOS) highly expressed in
MΦs [10,12].
Prostaglandins are other important inflammatory me-
diators implicated in the vascular homeostasis since its
low levels can prevent or reverse aggregation of platelets
and induce vasodilation [9,13]. These molecules are pro-
duced from arachidonic acid metabolites by the catalysis
of cyclooxygenase-2 (COX-2) [14].
Pro-inflammatory cytokines induce integrin expression
and redistribution of leukocytes, which contribute to
their recruitment and activation at the site of inflamma-
tion [15,16], as well as increasing vascular permeability
and tissue injury [17,18]. There is evidence that inflam-
matory cytokines are the main orchestrators of the in-
flammatory cascade in BRDC, detecting high levels of
TNFα and IL-1 in the airways of cattle infected with re-
spiratory pathogens [19-22].
BVDV is a pestivirus that although it is not a primary
agent in the pathogenesis of BRDC, it can suppress the
host immune system and increase the risk of secondary
infections, thus enhancing pulmonary colonization by
other pathogens such as BHV-1 [23-25]. The mecha-
nisms of the immunosuppressive action of BVDV are
object of debate, including changes related to decreased
lymphocyte proliferation [26,27], severe lymphoid deple-
tion in lymphoid tissues [28-30], decreased chemotaxis
and phagocytic activity [31], increased production of
prostaglandin E2 [32,33], increased NO synthesis in re-
sponse to lipopolysaccharide [34,35] and impaired pro-
duction of pro-inflammatory cytokines [30,36-39].
Therefore, the aim of this study was to clarify the
mechanisms responsible for ultrastructural and histo-
pathological changes occurring in the lungs of calves
pre-infected with BVDV and challenged later with BHV-1,
as well as to analyze the role of MΦs in the appearance
of the lesions. Thus, this work will contribute to gaining
a better understanding about how this virus predisposes
to secondary airborne infections.
Materials and methods
Experimental design
The experimental design and collection of samples have
been described by Risalde et al. [40]. Briefly, twenty-four
Friesian calves (8–9 months old), BVDV and BHV-1
antigen and antibody (Ab) free, were housed in the Ani-
mal Experimental Center of Cordoba University (Spain).
The animals had an adjustment period of one week be-
fore the study started and were separated into three
groups based on the inoculation protocol: twelve calveswere inoculated intranasally with 10 mL of a suspension
of non-cytopathic BVDV-1 strain 7443 with a titration
of 105 tissue culture infective dose 50% (TCID50)/mL
(courtesy of the Institute für Virologie, TIHO, Hannover,
Germany). Twelve days later, when the calves showed
neither clinical signs nor BVDV viraemia, they were
challenged with 2 mL of BHV-1.1 strain Iowa containing
107 TCID50/mL (courtesy of the Hipra Laboratories,
Girona, Spain) (BVDV/BHV-1 group). Two calves of this
group, BHV-1.1-free, were used as BVDV infection con-
trols. At the same time, ten calves were inoculated only
with BHV-1.1 (BHV-1 group). Two un-infected (UI) ani-
mals were used as negative controls and received intra-
nasally 2 mL of tissue culture fluid free of viruses. The
time point of BHV-1.1 inoculation was defined as day 0.
After virus inoculation, clinical examination was
performed daily. In order to determine the number of
platelets, EDTA blood obtained from coccygeal vein and
nasal swab samples were collected at 0, 3, 6, 9, 12, 15, 18
and 21 hours post-inoculation, 1, 2, 4, 5, 7, 9, 12 and 14 -
days post-inoculation (dpi) with BHV-1.1. The infected
calves were sedated with xylazine (RompunW 2% solu-
tion; Bayer Healthcare, Kiel, Germany) and euthanized
by overdosing with thiopental-sodium (ThiovetW; Vet
Limited, Leyland, Lancashire, UK) in batches of two at 1,
2, 4, 7 and 14 dpi. Two animals of the BVDV/BHV-1
group were killed at 0 dpi just before BHV-1.1 inocula-
tion (BHV-1.1-UI), being used as BVDV infection con-
trols for this group. On the contrary, the two negative
control animals were euthanized at the end of the study,
being used as UI controls for the BHV-1 group. The ex-
perimental procedure was carried out in accordance
with the Code of Practice for Housing and Care of Ani-
mals used in Scientific Procedures, approved by the
European Economic Community in 1986 (86/609/EEC
amended by the directive 2003/65/EC).
All euthanized calves were subjected to necropsy exam-
ination. The samples were collected from the lungs and
immediately frozen at −80°C for virological study; likewise,
they were fixed in 10% buffered formalin solution for
histopathological and immunohistochemical studies as
well as in 2.5% glutaraldehyde in 0.1 M PBS for ultrastruc-
tural analysis.
Lung tissue samples were analyzed to discard any in-
fection with secondary bacterial pathogens, being
subjected to microbiological routine cultures (Xylose ly-
sine deoxycholate agar, MacConkey agar and Blood agar)
by using standard procedures. No bacteria were isolated
from these samples.
Polymerase chain reaction (PCR)
RNeasy Lipid tissue kit (Qiagen) was used to extract
BVDV ribonucleic acid (RNA) from lung samples,
according to the manufacturer’s instructions. This RNA
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tion plus Polymerase Chain Reaction (RT-PCR) using
primers and Taqman probes (at the same concentration)
from conserved regions of the 5’-UTR of BVDV-1a [41].
The reaction was performed using the Real Time Ready
RNA Virus Master (Roche, Mannheim, Germany) in a
LightCycler 1.5, according to the manufacturer’s instruc-
tions. The samples with a cycle threshold value less
than or equal to 45 were considered as positive. The
positive control was the NCP BVDV-1 strain 7443 at
105 TCID50/mL.
A real-time PCR analysis of the BHV-1 deoxyribo-
nucleic acid (DNA), extracted from lung samples using
Genomic DNA from a tissue kit (Macherey-Nagel,
Germany), was performed according to the OIE Terres-
trial Manual [42]. After analyzing the results on an Ap-
plied 7300 detector (Applied Biosystems, USA), any
sample with a cycle threshold value less than or equal to
45 was considered as positive. The positive control was
the BHV-1.1 strain Iowa at 108.3 TCID50/mL.
Tissue sample collection and processing for transmission
electron microscopy (TEM)
Glutaraldehyde-fixed samples were post-fixed in 2% os-
mium tetroxide, dehydrated in acetone and embedded in
Epon 812W (Fluka Chemie AG, Buchs, Switzerland). Sec-
tions (50 nm) were counterstained with uranyl acetate
and lead citrate, and examined with a Philips CM-10
transmission electron microscope.
Immunohistochemical methods
Formalin-fixed samples were dehydrated through a
graded series of alcohol to xylol and embedded in paraf-
fin wax by routine techniques for light microscopy. Sam-
ples were sectioned (3 μm) and stained by different
methods as haematoxylin-eosin and the Fraser Lendrum
technique, or processed for their immunohistochemical
study using the avidin-biotin-peroxidase complex (ABC)
method.Table 1 Detailed list of primary antibodies used in the immun
Specificity Antigen or cell detected m
Anti-human MΦs Monocytes and MΦs
(clon
Anti-bovine TNFα TNFα
Anti-human IL-1α IL-1α
Anti-murine iNOS/NOS Type II iNOS/NOS Type II
Anti-murine COX-2 COX-2
Anti-Human Von Willebrand Factor Von Willebrand Factor
MΦs, macrophages; mAb, monoclonal antibody; pAb, polyclonal antibody.
a Incubation with 0.1% protease type XIV (Sigma–Aldrich Chemie) in 0.01 M PBS, pH
b Incubation with 0.1 M citric acid (pH 6), microwave for 5 min at sub-boiling tempe
c Incubation with 0.1% Tween 20 (Merck) in 0.01 M PBS, pH 7.2, for 10 min at room
d Incubation with 0.1 M citric acid (pH 6) and autoclaved for 30 min at 121°C, 1 atmThe ABC method for immunohistochemistry (IHC)
was performed on serial sections of formalin-fixed sam-
ples, which were dewaxed and rehydrated as previously
described by Pedrera et al. [29,38]. Briefly, endogenous
peroxidase activity was exhausted by incubation with
0.3% hydrogen peroxide in methanol for 30 min at room
temperature. The samples were subjected to different
methods for antigen retrieval (Table 1). After pre-
treatment, the sections were rinsed three times in PBS
(pH 7.2) for 10 min and then covered with 1% normal
horse serum (Pierce-Endogen, Woburn, USA) in 0.05 M
Tris buffered saline (TBS) (pH 7.6) or 20% normal goat
serum in PBS for 30 min at room temperature, for pri-
mary monoclonal Ab(mAb) and polyclonal Ab(pAb), re-
spectively. After this blocking stage, sections were
incubated with primary Ab at 4°C overnight. After pri-
mary incubation, the slides were washed in PBS (three
times for 5 min each) and then incubated with the sec-
ondary antibodies for 30 min at room temperature.
Biotinylated horse anti-mouse IgG secondary Ab
(Pierce-Endogen) diluted 1:200 in Tris buffer containing
normal horse serum 1% was used for the primary mAb.
Biotinylated goat anti-rabbit IgG secondary Ab (Vector
Laboratories, Burlingame, CA, USA) diluted 1:200 in
PBS containing normal goat serum 1.5% was used for
the primary pAb. After three further 5 min washes in
TBS, samples were incubated with the ABC complex
(VectastainW ABC Elite Kit, Vector Laboratories, CA,
USA) for 1 h at room temperature. All tissue sections
were finally rinsed in PBS and incubated with chromo-
gen solution (NovaREDW Substrate Kit, Vector Labora-
tories). Slides were counterstained with Mayer’s
haematoxylin. Details of the primary mAb and pAb are
summarized in Table 1.
Tissue samples from cattle, in which reactivity for pri-
mary Ab against cytokines and cellular markers used in
this study had been demonstrated, were used as positive
controls in IHC [29,38]. Tissue sections for which the
specific primary Ab were replaced by rabbit or mouseohistochemical study
Ab/pAb Dilution Pre-treatment Source
mAb 1:100 Proteasea Serotec
e MAC387)
pAb 1: 25 TC-microwaveb Serotec
pAb 1:100 Tween-20c Endogen
pAb 1:100 TC-autoclaved BD Transduction Lab.
pAb 1:75 TC-autoclaved Cayman Chemical
pAb 1:800 Proteasea DakoCytomation
7.2, for 10 min at room temperature.
rature.
temperature.
.
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were used as negative controls.Cell counting and statistical analysis
In order to evaluate the number of immunolabeled cells
and to correlate the results obtained using different Ab,
two paraffin-wax blocks from the lungs of each animal
were selected. Cell counts were carried out on 50 ran-
domly chosen fields of 0.2 mm2 from tissue sections
from these blocks. The results are given as the number
of positive cells per 0.2 mm2. Identification of different
types of immunolabeled cells was based on morpho-
logical features, location and size of the cells.
The different pulmonary MΦs exhibited rounded or
elongated morphology, an indented nucleus and abun-
dant cytoplasm. Interstitial MΦs (IMΦs), pulmonary
intravascular MΦs (PIM) and pulmonary alveolar MΦs
(PAM) are localized in distinct anatomical compart-
ments of the lung, including connective tissue, being ad-
hered to the endothelium in the pulmonary capillaries and
air spaces, respectively. PIM and IMΦs were grouped to-
gether and are described as “septal MΦs”.
A semiquantitative estimation of platelet aggregation
Factor-VIII-positive was performed on 50 randomly
chosen 0.2 mm2 areas. The results are given as the pres-
ence of positive clusters of platelets per area as follows:
absent (−), mild (+), moderate (++) and abundant (+++).
For graphical representation and statistical analysis, they
were scored from absent to severe (0 to 3).
Quantifications were performed by two experienced
observers but with no previous knowledge of which
group was being analyzed. Data were assessed to calcu-
late mean ± standard error values and were analyzed
with the SAS System for Windows, version 9.1 (SAS In-
stitute, Cary, North Carolina, USA). Chi-square analysis
was employed for the estimation of platelet aggregation
Factor-VIII-positive for which a p < 0.05 was accepted as
statistically significant, using a Fisher’s exact test in the
instance of an expected value below 5. The Duncan’s
Multiple Range Test (p < 0.05) was used to analyze sig-
nificant differences of the values in the same group at
various time points (*) and non-paired Student’s t-test
(p < 0.05) was used between both inoculated groups at
the same time point (**).Results
Respiratory signs and hematological findings
The main respiratory signs are given in Risalde et al. [40].
Briefly, the calves pre-infected with BVDV show more in-
tense respiratory signs such as cough, mucopurulent nasal
discharge, dyspnoea and open-mouth breathing mainly
between 4 and 11 dpi, while the calves of the BHV-1
group only presented a moderate serous nasal discharge.Platelet numbers were within the clinically normal
range in all calves throughout the study, except for 2 an-
imals from both inoculated groups, where an important
decrease of platelet numbers to approximately 57% was
observed at 12 hpi.
Detection of BVDV and BHV-1 in the lungs
The presence of BVDV in the lungs of co-infected calves
was detected by RT-PCR between 0 and 7 dpi (12–19
dpi BVDV), presenting the samples cycle threshold
values between 33 and 39; whereas BHV-1 was detected
by PCR from 2 to 14 dpi in these calves with cycle
threshold values from 35 to 40. On the contrary, BHV-1
was only detected between 4 and 7 dpi in the BHV-1
group, showing the samples higher cycle threshold
values (between 41 and 42), while BVDV was not
detected in these calves throughout the study.
Respiratory lesions
There were no remarkable lesions in the negative con-
trol animals. The pulmonary parenchyma of inoculated
calves was affected by interstitial pneumonia with alveo-
lar septal thickening produced by interstitial aggregates
of mononuclear cells. The appearance of this alteration
was earlier in the co-infected calves and was associated
with occasional haemorrhages.
The fraser Lendrum technique revealed fibrin microthrombi
in some pulmonary venules and capillaries of inoculated
calves, being more severe in co-infected calves, mainly
from 4 dpi onwards (Figure 1A). These changes were con-
firmed by the ultrastructural study together with the pres-
ence of fibrin in alveoli associated with PAM in both
inoculated groups at early stages (Figure 1B). Moreover,
these animals displayed an intense hyperaemia as well as
interstitial and alveolar oedema during this period.
These findings were associated with a great quantity of
platelets, whose detection was performed by IHC using
anti-Factor-VIII Ab. Thus, in the negative control calves,
this Ab prompted positive granular immunostaining
among sheathed capillary cells, free in the interstitium
and occasionally in MΦs cytoplasm. However, in the in-
oculated groups, clusters of immunostained granular
material were observed in blood vessels. Moreover, nu-
merous IMΦs and periarterial MΦs, together with some
PAM, were swollen and displayed an intense positive
granular and cytoplasmic reaction in both inoculated
groups between 4 and 7 dpi (Figure 2A, 2B). In the
BVDV/BHV-1 group, clusters of platelets were observed
from 1 dpi, being more evident throughout the study as-
sociated with MΦs engulfing platelets that peaked at 4
dpi (score value of 3 in all evaluated fields) (Figure 3).
Subsequently, the positive reaction in MΦs and vascular
lumina diminished considerably without recovering
thereafter (Figure 2C). There was a significant difference
Figure 1 (See legend on next page.)
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Figure 1 Fibrin microthrombi in pulmonary venules of animals pre-infected with BVDV and challenged later with BHV-1.1. Co-infected
animals presented vascular alterations that facilitate the occlusion of the pulmonary venules as fibrin microthrombi observed with Fraser Lendrum
technique (A) and TEM (B) at 4 dpi, as well as PIM enlarged and rounded engulfing cell debris (arrowheads) observed with TEM at 4 dpi (C).
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throughout the study (p = 0.0119). In the BHV-1 group,
these findings were observed from 2 dpi with similar
values to the co-infected group, decreasing the number
of platelet clusters until the end of the study (Figures 2D
and 3). However, there was no significant difference in
the incidence of these clusters in the lungs of animals
infected only with BHV-1.
Ultrastructural studies confirmed that there was an in-
crease in the number of activated platelets forming mul-
tiple aggregations within the blood vessels, whose
vascular lumina usually appeared completely occluded.
The changes indicative of this activation were an en-
larged and deformed shape of the cells, a partial or total
decrease in granule numbers and a dilation of the open
canalicular system. The most common form of platelet
aggregation was the appearance of mosaic-like clusters
comprising fully degranulated platelets with fusion of
cytoplasmic membranes. Occasionally, these membranes
completely disappeared, giving rise to a finely granularFigure 2 Immunohistochemical detection of pulmonary platelet clust
BHV-1.1. Immunohistochemical study of the lung in these animals reveale
Factor VIII-positive clusters of platelets in some pulmonary venules and cap
1 group (B), where IMΦs and periarterial MΦs were observed engulfing po
showed lower quantities of platelet clusters at 14 dpi (C), with this lesion instructure with low electron density, containing vestiges
of platelet organelles and surrounded by a membrane
layer. In the BVDV/BHV-1 group, platelet aggregation
occurred sooner and was more intense, increasing be-
tween 4 and 7 dpi (Figure 4A) and not showing a total
recovery at the end of the study (Figure 4C). In the
BHV-1 group this lesion was moderate, presenting re-
trieval signs from 7 dpi (Figure 4B, 4D).
Subcellular changes indicative of a slight secretory ac-
tivation in IMΦs such as enlargement, proliferation and
dilation of rough endoplasmic reticulum and Golgi com-
plex cisternae were mainly observed in the BHV-1 group
at 4 dpi. Moreover, from 4 dpi, some PIM and PAM of
both inoculated groups appeared enlarged and rounded,
with loss of filopodia, increased number of lysosomes
and varying amounts of cell debris in their cytoplasm,
characteristic signs of phagocytic activation (Figure 1C).
Immunolabeling of septal MΦs displayed similar kinet-
ics in single and dual infections after BHV-1.1 inocula-
tion, although presenting differences in the magnitude ofers in calves with and without pre-existing BVDV challenged with
d that the calves of the BVDV/BHV-1 group showed a great quantity of
illaries at 4 dpi (A), compared with minor changes present in the BHV-
sitive granular material. Moreover, the calves of the BVDV/BHV-1 group
the BHV-1 group being almost inexistent at this time (D).
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Figure 3 Representative graphic of the valuation of factor VIII-positive platelet clusters detected by immunohistochemical method.
These score values were obtained for the analysis of 100 fields (0.2 mm2 each) from the lung of calves (n = 2 per time point) inoculated with
BHV-1.1 (a) versus calves inoculated with BVDV and BHV-1.1 (b). The results are given as follows: absent (−), mild (+), moderate (++) and
abundant (+++), and scored from absent to severe (0 to 3). (UI, BHV-1.1 un-infected: negative controls for the BHV-1 group and BVDV infection
controls for the BVDV/BHV-1 group).
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higher number of these cells during the study, peaking
at 4 dpi (p < 0.0001). The number of PAM was also sig-
nificantly higher in the co-infected calves at the start of
the study, showing a decrease from 4 dpi (Figure 5).Figure 4 Ultrastructural detection of pulmonary platelet clusters in ca
1.1. The analysis of the samples with transmission electron microscopy con
blood vessels with some vascular lumina completely occluded (arrowheads
lesion (arrowheads) observed in the BHV-1 group (B). Pulmonary parenchym
infected group at 14 dpi (C), in comparison with a total recuperation (arrowSecretory activity of MΦs observed ultrastructurally
was confirmed by IHC, which enabled the detection of
MΦs-secreted inflammatory mediators.
TNFα and IL-1α-producing cells, identified as septal
MΦs and PAM, were detected immunohistochemicallylves with and without pre-existing BVDV challenged with BHV-
firmed the presence of multiple aggregations of platelets within the
) in the lungs of the BVDV/BHV-1 group at 4 dpi (A), versus a mild
a showed recovery signs of this lesion (arrowheads) in the co-
heads) in the single infection (D).
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Figure 5 Septal MΦs and PAM (means ± standard errors) positive for MAC387 by immunohistochemical method. The values were
evaluated in the lung of calves co-infected experimentally with BVDV and BHV-1.1 compared with calves inoculated only with BHV-1.1 (n = 2 per
time point). (UI, BHV-1.1 un-infected: negative controls for the BHV-1 group and BVDV infection controls for the BVDV/BHV-1 group. *p < 0.05
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time point).
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proinflammatory cytokines presented differences in mag-
nitude and kinetics between single and dual infections.
TNFα-positive septal MΦs were associated with sites of
inflammation in the BVDV/BHV-1 group (Figure 6A),
showing only a slight peak at 2 dpi (p < 0.008), whereas
the BHV-1 group presented a longer response of this
chemical mediator in peribronchial areas (from 4 dpi;
p < 0.0001) (Figure 6B). On the contrary, IL-1α-reactive
septal MΦs were significantly different between both
infected groups before BHV-1 inoculation (0 dpi BHV-1).
BVDV/BHV-1 group calves maintained lower numbers
of IL-1α-positive septal MΦs throughout the study
(Figure 6C), showing a delayed response to BHV-1
inoculation (from 7 dpi onwards). By contrast, BHV-1group calves displayed an early increase of this cytokine
associated with peribronchial areas (at 2 dpi; p < 0.007)
(Figure 6D). The number of PAM positive for studied
cytokines was low in both inoculated groups, presenting
only a slight response at the end of the study, with the
exception of an IL-1α peak in the single infected group
between 1 and 2 dpi (Figure 7).
Numerous groups of immunolabeled septal MΦs pre-
senting iNOS-positive cytoplasmic granules, mainly
IMΦs, were observed in the pulmonary parenchyma of
animals infected only with BVDV (Figure 8A). After
BHV-1 inoculation, in BVDV/BHV-1 group calves, sep-
tal MΦs expressing iNOS decreased significantly until
the end of the experiment (p < 0.0001), showing values
of approximately twice below the baseline level from 4
Figure 6 Pro-inflammatory cytokines in the lungs of calves with and without pre-existing BVDV challenged with BHV-1.1. An
immunohistochemical study revealed the presence of septal MΦs and PAM positive for TNFα (A) and IL-1α (C) associated with sites of
inflammation in the pulmonary parenchyma of the BVDV/BHV-1 group at 2 dpi. However, the calves of the BHV-1 group presented a higher
number of IMΦs reactive to TNFα (B) and IL-1α (D) in the peribronchial areas of the lung at 2 dpi.
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a similar response after BHV-1 inoculation; although in
these animals the decrease of this mediator was ob-
served later than in the BVDV/BHV-1 group. On the
contrary, the number of iNOS-positive PAM was higher
in the BVDV/BHV-1 group and did not suffer changes
throughout the study, while BHV-1 group calves showed
a significant decrease from 7 dpi (Figure 7).
Intracellular localization of COX-2 was perinuclear and
cytoplasmic in the MΦs, being its expression scarce in the
lungs during the study (Figure 8C), except for septal MΦs
of the BVDV/BHV-1 group at 4 dpi (p < 0.0001) (Figure 7).
This intense expression occurred at sites of inflammation
and injury, mainly oedemas, and was correlated with the
degree of pulmonary inflammation (Figure 8D).
Discussion
The objective of this study was to evaluate and characterize
the vascular changes observed in the lungs of healthy
calves and calves with subclinical BVD both experimentally
inoculated with BHV-1.1, and to clarify the role of the pul-
monary MΦs in the local response to the secondary
pathogen.
The results show that following BHV-1 inoculation,
both groups of calves displayed a mononuclear cellinfiltrate and prompted major vascular alterations in the
lungs, marked by intense intravascular coagulation in
small and medium-sized blood vessels from an early
stage of the disease. Three mechanisms, jointly known
as Virchow’s triad, can induce thrombosis [43]: 1) endo-
thelial wall injury; 2) abnormalities of blood constituents
(platelets, coagulation and fibrinolytic pathways); and 3)
abnormalities of blood flow.
With regard to endothelial damage, infection by human
herpes simplex virus – belonging to the same subfamily
that BHV-1 [44] – has been shown to cause endothelial
injury, favoring the exposure of subendothelial tissue and
the release of procoagulant mediators [45,46]. Here, how-
ever, neither histopathological nor ultrastructural examin-
ation disclosed any morphological evidence of endothelial
damage in either of the inoculated groups.
Analysis of the cell components involved in coagula-
tion pathways revealed fibrin deposits and intense plate-
let aggregation in the pulmonary microvasculature of
both groups; these findings were particularly marked in
the BVDV/BHV-1 group at 4 dpi, coinciding with a sig-
nificant increase of the rectal temperature and severe
clinical respiratory symptoms [40]. According to this, in
the course of certain acute viral infections, platelets may
be activated in vivo, leading to their degranulation,
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Figure 7 Septal MΦs and PAM (mean ± standard error) positive for TNFα, IL-1α, iNOS and COX-2. Immunohistochemical study revealed
changes in the lungs of calves co-infected experimentally with BVDV and BHV-1.1 compared with calves inoculated only with BHV-1.1 (n = 2 per
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http://www.veterinaryresearch.org/content/44/1/20aggregation and withdrawal from circulation [47-49]. The
procoagulant activity of BVDV and BHV-1 has been
reported in vitro [50]. In our experimental study, it was in-
creased in the co-infected calves due to the concomitance
of both agents in the lungs between 2 and 7 dpi. Despite
the absence of BVDV in the blood of these calves at the
moment of BHV-1 inoculation, it does not completely dis-
appear, being detected by PCR in the lungs and by IHC in
lymphoid tissues throughout the experience [51]. However,
there was no evidence in any stage of direct interaction be-
tween these viruses and platelets, which would suggest that
platelet activation may be enhanced by indirect mecha-
nisms including the expression of inflammatory mediatorsreleased by MΦs, which are known to play a major role in
the maintenance of tissue homeostasis [11,52].
The study of pro-inflammatory cytokines revealed alter-
ations in the kinetics and magnitude of TNFα and IL-1
expression; both mediators can prompt changes in
coagulation by increasing the number of endothelial
adhesion molecules or increasing vascular permeability
[11,53]. Thus, the BVH-1 group calves display an in-
crease in IL-1 synthesis by septal MΦs coinciding with
the onset of platelet aggregation in the lungs (2 dpi).
This, together with the subsequent action of TNFα,
would favor the maintenance of the procoagulant set-
ting. By contrast, BVDV/BHV-1 group calves, whilst
Figure 8 Immunohistochemical detection of iNOS and COX-2 in the lungs of BVDV pre-infected calves challenged with BHV-1.1.
Numerous immunolabeled septal MΦs iNOS-positive were observed in the lungs of calves inoculated only with BVDV (0 dpi of BVDV/BHV-1
group) (A), versus a minor number of these cells at 4 dpi BHV-1.1 (B). Pulmonary parenchyma of calves inoculated only with BVDV (0 dpi of
BVDV/BHV-1 group) showed an absence of MΦs positive for COX-2 Ab (C), compared with numerous immunolabeled MΦs COX-2-positive
observed in the sites of inflammation at 4 dpi (D).
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http://www.veterinaryresearch.org/content/44/1/20exhibiting a higher number of IMΦs – the main pro-
ducers of these cytokines – displayed inhibited IL-1
expression until 7 dpi, along with a minimal TNFα re-
sponse. This impaired cytokine production, also ob-
served at the systemic level [40], indicates that the
synergic action of both chemical mediators can be
ruled out as a potential mechanism for inducing plate-
let aggregation in the co-infected group.
Calves inoculated only with NCP BVDV (0 dpi for the
BVDV/BHV-1 group) displayed greater expression of
iNOS by septal MΦs than healthy calves [34,35,54].
However, following BHV-1 inoculation, BVDV/BHV-1
group calves exhibited an early decline in iNOS (1 dpi),
an inflammatory mediator that limits the extent and
duration of pathogen-induced platelet activation [55].
This finding, together with the moderate response of
TNFα, may have favored the appearance of platelet ag-
gregates in the early stages of the disease, and intense
aggregation coinciding with the greatest decrease in
iNOS levels (4 dpi).
The intense platelet aggregation observed in the lung
microvasculature of the BVDV/BHV-1 group at 4 dpi,
together with the increase in number and size of PIM as
a result of phagocytic and secretory activation would in-
directly prompt a slowdown in blood flow and asubsequent response by the COX-2 enzyme aimed at re-
versing that process [13]. However, in view of the dam-
age observed at later stages, this action was presumably
unable to counter the procoagulant events associated
with the drop in iNOS expression, these being additionally
enhanced by the delayed action of IL-1 in co-infected
animals. Slowed blood flow, together with cytokine
release, may lead to increased vascular permeability and
extravasation of leukocytes into the pulmonary par-
enchyma [11,53,56,57].
Therefore, the results of this study indicate that the con-
comitance of BVDV and BHV-1 in the lungs enhances a
synergic action of their pathogenic mechanisms, disrupting
the maintenance of pulmonary homeostasis by facilitating
the establishment of an inflammatory and procoagulant
environment, characteristic of the BRDC, which appears to
be modulated by inflammatory mediators released by pul-
monary MΦs. In this respect, further research is required
into the possible involvement of this concomitance,
through the use of live BVDV and BHV-1 vaccines, in the
triggering of an impaired pulmonary immune response.
On the contrary, animals pre-inoculated with BVDV -
despite suffering a transient infection - exhibit an alter-
ation in the response of pro-inflammatory cytokines which
play a key role in activating the immune response.
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